| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Options Exercise | $0 | +1,771 | +14% | $0.000000 | 14,615 | 01 Jul 2021 | Direct | F1 |
| transaction | BSX | Common Stock | Sale | $29,946 | -700 | -4.8% | $42.78 | 13,915 | 01 Jul 2021 | Direct | F2 |
| transaction | BSX | Common Stock | Tax liability | $37,897 | -874 | -6.3% | $43.36 | 13,041 | 01 Jul 2021 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -1,771 | -25% | $0.000000 | 5,315 | 01 Jul 2021 | Common Stock | 1,771 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
| F2 | This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan. |
| F3 | Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2021, the first anniversary of the date of grant. |